Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, today announced its appointment of Robin Mackie as president of Ideanomics Mobility — a division of…
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it is formally beginning the process towards an Investigational New Drug (“IND”) application filing with the Food and Drug Administration…
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced its participation at the H.C. Wainwright 23rd…
InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and…
Investor appetite in Africa continues to be robust, attracting $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018 Agriculture makes up 23 percent of sub-Saharan Africa’s GDP and 60 percent of employment Tingo…
AnPac Bio-Medical Science Co., Ltd. held its 2021 technical symposium, entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment” in Shanghai, China, on August 6, 2021 The symposium included attendees from various hospitals,…
Lexaria Bioscience Corp. and its patented DehydraTECH technology promote a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro, and human clinical testing DehydraTECH is sub-licensed to other companies…
Sustainability cultivator Ideanomics has reached an agreement with commercial EV vehicle manufacturer VIA Motors to acquire VIA in an all-stock transaction valued at $450 million The VIA acquisition will solidify Ideanomics’ position as a made-in-America…
SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. SRAX has upgraded the user experience on Sequire to add a new…
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its appointment of Fred Leigh as a director and executive chairman of the company’s board of directors. PlantX also announced that it has dissolved its…
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its receipt of adult use (recreational use) prequalification status pursuant to the licensing provisions of…
PlantX’s operations are firmly anchored on three operational focal points, namely products, distribution and community The company is also guided by a growth strategy, under which the e-commerce platform is the main driver of growth…
SRAX offers a premier investor intelligence and communications platform branded Sequire for clients to track investors’ behavior and trends, and engage shareholders SRAX is hosting its first Sequire EdTech Conference on September 13, 2021, which…
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its 2021 export quota from the Colombian Technical Quotas Group (“TQG”) of 7,900 kilograms of high-THC cannabis…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (“CBD”), demonstrates up to a 23% decrease in blood pressure when…
AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd., one of its subsidiaries; the increase came after approval was granted…
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that a tolerability and pharmacokinetic study, performed by an independent, premier animal testing laboratory in the U.S., had demonstrated that administration of colchicine using its proprietary DehydraTECH(TM) resulted…
FingerMotion (OTCQX: FNGR) is an evolving technology company with three operational and revenue-generating business units – TPS, SMS & MMS, and Big Data – with plans to make a fourth division, the rich communication services…
Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently announced the launch of its call center. “The WeChat call center is designed to help businesses build an automated and personalized private domain…
FNGR currently services over a billion users, specifically in the Chinese market It is a company committed to delivering the next generation of data-driven tech solutions across its current product line and service offerings FNGR…